Furore among rival firms as HPV (human papilloma virus) beats cytology in screening study
This article was originally published in Clinica
Prompting fierce debate between rival firms, a controversial Lancet study has found that human papilloma virus (HPV- testing is better for cervical cancer screening than the standard Pap cytology test. The findings could have huge connotations, potentially leading to a large-scale switch across Europe from cytology to HPV testing. Cytology (smear) tests would still be used, but in a confirmatory capacity.